Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and the Illinois Chapter of the American Cancer Society
Sojin Shikano, PhD, DVM
University of Illinois at Chicago College of Medicine
Chicago
IL
KCNK9 potassium channel activity is involved in the development of cancer, including lung cancers. Dr. Shikano is studying how this activity is regulated. An understanding of this process may lead to the development of a treatment that targets the channel activity.
Key words